GlassScriptPhysician profile
Eun Taek Yoon
NPI 1750907499
$2,270.90
in general payments reported to CMS, 2019-2025
10 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,779 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,427 · Travel and Lodging: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,427.17 |
| Travel and Lodging | $843.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,108.52 | 2024 | |
| Abbvie INC. | $271.55 | 2024-2025 | |
| Astellas Pharma US INC | $153.53 | 2024-2025 | Izervay |
| Tarsus Pharmaceuticals, INC. | $142.86 | 2024 | |
| Genentech USA, INC. | $140.27 | 2025 | Susvimo |
| Oyster Point Pharma, INC. | $125.00 | 2024 | Tyrvaya |
| Apellis Pharmaceuticals, INC. | $105.61 | 2024 | Syfovre |
| Nova Eye, INC. | $105.12 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $92.90 | 2024 | Eylea Hd |
| Amgen INC. | $25.54 | 2024 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eun Yoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.